Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol

In France, around 5% of the general population are taking drug treatments for diabetes mellitus (mainly type 2 diabetes mellitus, T2DM). Although the management of T2DM has become more complex, most of these patients are managed by their general practitioner and not a diabetologist for their antidia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paul Quindroit, Nicolas Baclet, Erwin Gerard, Laurine Robert, Madleen Lemaitre, Sophie Gautier, Chloé Delannoy-Rousselière, Bertrand Décaudin, Anne Vambergue, Jean-Baptiste Beuscart
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/bec2e1891000414c81f06c4114983ed8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bec2e1891000414c81f06c4114983ed8
record_format dspace
spelling oai:doaj.org-article:bec2e1891000414c81f06c4114983ed82021-11-25T17:45:52ZDefining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol10.3390/healthcare91115392227-9032https://doaj.org/article/bec2e1891000414c81f06c4114983ed82021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9032/9/11/1539https://doaj.org/toc/2227-9032In France, around 5% of the general population are taking drug treatments for diabetes mellitus (mainly type 2 diabetes mellitus, T2DM). Although the management of T2DM has become more complex, most of these patients are managed by their general practitioner and not a diabetologist for their antidiabetics treatments; this increases the risk of potentially inappropriate prescriptions (PIPs) of hypoglycaemic agents (HAs). Inappropriate prescribing can be assessed by approaches that are implicit (expert judgement based) or explicit (criterion based). In a mixed, multistep process, we first systematically reviewed the published definitions of PIPs for HAs in patients with T2DM. The results will be used to create the first list of explicit definitions. Next, we will complete the definitions identified in the systematic review by conducting a qualitative study with two focus groups of experts in the prescription of HAs. Lastly, a Delphi survey will then be used to build consensus among participants; the results will be validated in consensus meetings. We developed a method for determining explicit definitions of PIPs for HAs in patients with T2DM. The resulting explicit definitions could be easily integrated into computerised decision support tools for the automated detection of PIPs.Paul QuindroitNicolas BacletErwin GerardLaurine RobertMadleen LemaitreSophie GautierChloé Delannoy-RousselièreBertrand DécaudinAnne VambergueJean-Baptiste BeuscartMDPI AGarticlestudy protocoltype 2 diabeteshypoglycaemic agentspotentially inappropriate prescriptionsinappropriate prescribingmethodology researchMedicineRENHealthcare, Vol 9, Iss 1539, p 1539 (2021)
institution DOAJ
collection DOAJ
language EN
topic study protocol
type 2 diabetes
hypoglycaemic agents
potentially inappropriate prescriptions
inappropriate prescribing
methodology research
Medicine
R
spellingShingle study protocol
type 2 diabetes
hypoglycaemic agents
potentially inappropriate prescriptions
inappropriate prescribing
methodology research
Medicine
R
Paul Quindroit
Nicolas Baclet
Erwin Gerard
Laurine Robert
Madleen Lemaitre
Sophie Gautier
Chloé Delannoy-Rousselière
Bertrand Décaudin
Anne Vambergue
Jean-Baptiste Beuscart
Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol
description In France, around 5% of the general population are taking drug treatments for diabetes mellitus (mainly type 2 diabetes mellitus, T2DM). Although the management of T2DM has become more complex, most of these patients are managed by their general practitioner and not a diabetologist for their antidiabetics treatments; this increases the risk of potentially inappropriate prescriptions (PIPs) of hypoglycaemic agents (HAs). Inappropriate prescribing can be assessed by approaches that are implicit (expert judgement based) or explicit (criterion based). In a mixed, multistep process, we first systematically reviewed the published definitions of PIPs for HAs in patients with T2DM. The results will be used to create the first list of explicit definitions. Next, we will complete the definitions identified in the systematic review by conducting a qualitative study with two focus groups of experts in the prescription of HAs. Lastly, a Delphi survey will then be used to build consensus among participants; the results will be validated in consensus meetings. We developed a method for determining explicit definitions of PIPs for HAs in patients with T2DM. The resulting explicit definitions could be easily integrated into computerised decision support tools for the automated detection of PIPs.
format article
author Paul Quindroit
Nicolas Baclet
Erwin Gerard
Laurine Robert
Madleen Lemaitre
Sophie Gautier
Chloé Delannoy-Rousselière
Bertrand Décaudin
Anne Vambergue
Jean-Baptiste Beuscart
author_facet Paul Quindroit
Nicolas Baclet
Erwin Gerard
Laurine Robert
Madleen Lemaitre
Sophie Gautier
Chloé Delannoy-Rousselière
Bertrand Décaudin
Anne Vambergue
Jean-Baptiste Beuscart
author_sort Paul Quindroit
title Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol
title_short Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol
title_full Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol
title_fullStr Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol
title_full_unstemmed Defining Potentially Inappropriate Prescriptions for Hypoglycaemic Agents to Improve Computerised Decision Support: A Study Protocol
title_sort defining potentially inappropriate prescriptions for hypoglycaemic agents to improve computerised decision support: a study protocol
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/bec2e1891000414c81f06c4114983ed8
work_keys_str_mv AT paulquindroit definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol
AT nicolasbaclet definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol
AT erwingerard definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol
AT laurinerobert definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol
AT madleenlemaitre definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol
AT sophiegautier definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol
AT chloedelannoyrousseliere definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol
AT bertranddecaudin definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol
AT annevambergue definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol
AT jeanbaptistebeuscart definingpotentiallyinappropriateprescriptionsforhypoglycaemicagentstoimprovecomputeriseddecisionsupportastudyprotocol
_version_ 1718412069223530496